Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

16 May 2013 07:00

RNS Number : 8281E
Wilmington Group Plc
16 May 2013
 



16 May 2013

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group, the provider of Information, Compliance, and Education to professional markets presents its Interim Management Statement for the period from 1 January 2013 to the date of this statement incorporating the Group's third quarter trading period to 31 March 2013.

 

 

Trading Review

 

The trading environment remains as reported in our interim results statement on 26 February 2013. As expected, revenue during the period from 1 January 2013 to the end of April 2013 is in line with the same four month period last year. Revenue from disposed businesses and discontinued marginal events has been offset by organic growth from our core businesses and revenues from acquired businesses. We have continued to see good growth in operating profits and improved operating margins across all the business divisions except, as previously reported, Business Intelligence which is impacted inter alia by the exiting of contract directory publishing.

 

The Group's third quarter trading was satisfactory, in line with the Board's expectations, with the continued emphasis on investing in and developing growth areas whilst removing underperforming marginal events. Across the divisions we have seen a continuation of the trading patterns reported at the interims.

 

Our higher margin Banking & Compliance, Pensions & Insurance businesses remain resilient with good renewals and revenue growth. On 1 March 2013, the Pensions & Insurance Division acquired the leading Spanish insurance market information business; Inese. The integration has gone well and March saw a successful contribution from the Inese flagship event; Insurance week.

Within the Healthcare division, reductions in sales of low margin UK mailing services and continued signs of uncertainty over recent NHS changes are affecting sales at the margin. This was offset by growth from its French medical news agency business. On 5 February 2013, the division acquired NHiS, a highly complementary provider of business intelligence on the UK healthcare market. NHiS has been integrated into the Group's systems and collaborative activities with other Wilmington Group companies have commenced.

 

As previously indicated, Business Intelligence's revenue has been adversely affected by the impact of exiting contract publishing.

 

The Accountancy division had a successful March trading month; its biggest and most important period, helped by demand surrounding the UK Government's annual fiscal budget.

 

As planned, the Legal Division revenue has been trimmed through a combination of removal of marginal events and the impact of the disposal of our Companies Formation business in June 2012.

 

Cash flow is strong and debt is reducing according to plan. During the period we utilised part of our £65m debt facility to acquire two businesses; NHiS in February and Inese in March 2013 for a net £5.0m and €1.4m respectively. As at the end of April 2013 our net debt was £37.6m (April 2012 £39.3m).

 

Outlook

 

The outlook for the full financial year remains unchanged and in line with the Board's expectations. Whilst economic conditions remain challenging, the majority of our businesses have been resilient and our internationally focussed divisions are still generating good growth. This growth, alongside contributions from our two recent acquisitions, and cost savings from initiatives already implemented, will help us achieve our full year expectations.

 

 

-End-

 

 

 

For further information, please contact:

 

Wilmington Group Plc

Charles Brady, Chief Executive

Tony Foye, Finance Director

 

FTI Consulting

Charles Palmer 

 

020 7422 6800

 

 

 

020 7831 3113

 

 

Notes to Editors

 

Wilmington Group plc is one of the UK's leading providers of Information, Compliance and Education for professional business markets. The Group provides business intelligence, information, training, education, events and support services for a variety of markets including the accountancy, banking, charities, financial services, healthcare, insurance, legal, and pensions sectors. Capitalised at approximately £135 million, Wilmington floated on the London Stock Exchange in 1995.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUUWAUPWGQA
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.